Lv4
786 积分 2022-10-18 加入
Recurrence of Hepatic Encephalopathy after TIPS: Effective Prophylaxis with Combination of Lactulose and Rifaximin
1个月前
已关闭
The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt
1个月前
已完结
Risk factors for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: A comprehensive minireview
1个月前
已关闭
Transjugular Intrahepatic Portosystemic Shunt: Devices Evolution, Technical Tips and Future Perspectives
1个月前
已关闭
AGA Clinical Practice Update on the Management of Ascites, Volume Overload, and Hyponatremia in Cirrhosis: Expert Review
1个月前
已完结
Chinese guidelines on the management of ascites in cirrhosis
1个月前
已关闭
[Guidelines on the management of ascites in cirrhosis (2023 version)]
1个月前
已完结
Transjugular Intrahepatic Portosystemic Shunt Using the New Gore Viatorr Controlled Expansion Endoprosthesis: Prospective, Single-Center, Preliminary Experience
1个月前
已关闭
The North American Study for the Treatment of Refractory Ascites
1个月前
已完结
Effects of transjugular intrahepatic portosystemic shunt using the Viatorr stent on hepatic reserve function in patients with cirrhosis
1个月前
已完结
皖公网安备34019202002308
